Tokyo Tape
Sign in
← Meiji Holdings

Quarterly report · Q3

2269.TEDINET S100Q6O2
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥798.1bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥1.01T2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥770.0bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥64.7bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥79.0bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥66.4bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥94.0bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥82.1bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥69.0bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥84.9bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥47.3bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥87.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥56.2bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥49.6bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥61.6bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥1.21Tat 2022-12-31Cons.Assets
Total assets¥1.12Tat 2022-03-31Cons.Assets
Total assets¥1.16Tat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥466.8bnat 2022-12-31Cons.Liabilities
Total liabilities¥404.4bnat 2022-03-31Cons.Liabilities
Net assets / equity¥748.1bnat 2022-12-31Cons.Net assets
Net assets / equity¥713.0bnat 2022-03-31Cons.Net assets
Net assets / equity¥696.4bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥87.7bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥67.4bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥85.9bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥64.9bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥60.8bnat 2021-12-31Cons.Cash and cash equivalents
Cash & equivalents¥39.0bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥36.7bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥127.5bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥75.1bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥41.8bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥27.6bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥45.4bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in investment activities
Financing cash flow¥21.3bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥77.0bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥9.8bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥336.242022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥99.132022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥607.242021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥387.812021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥135.32021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio58.2%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio60.3%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio56.5%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥557m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥557m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥1.4bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue2022-04-01 → 2022-12-31¥649.9bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue external2022-04-01 → 2022-12-31¥649.4bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥542m
jpcrp040300-q3r_E21902-000Foodreportable segmentsegment profit2022-04-01 → 2022-12-31¥45.1bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue2022-04-01 → 2022-12-31¥148.7bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue external2022-04-01 → 2022-12-31¥148.7bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥14m
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentsegment profit2022-04-01 → 2022-12-31¥21.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥798.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥798.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥557m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥66.2bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥775m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥775m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥1.1bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue2021-04-01 → 2021-12-31¥626.3bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue external2021-04-01 → 2021-12-31¥625.8bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥503m
jpcrp040300-q3r_E21902-000Foodreportable segmentsegment profit2021-04-01 → 2021-12-31¥61.7bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue2021-04-01 → 2021-12-31¥144.4bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue external2021-04-01 → 2021-12-31¥144.1bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥272m
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentsegment profit2021-04-01 → 2021-12-31¥18.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥770.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥770.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-12-31¥775m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥80.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 522
ItemContextValueUnit
Non controlling interestsPrior1YearInstant39684000000JPY
Non controlling interestsCurrentQuarterInstant40538000000JPY
Net assetsPrior1YearInstant713021000000JPY
Net assetsCurrentQuarterInstant748146000000JPY
Liabilities and net assetsPrior1YearInstant1117459000000JPY
Liabilities and net assetsCurrentQuarterInstant1214970000000JPY
Net salesPrior1YTDDuration769959000000JPY
Net salesCurrentYTDDuration798083000000JPY
Cost of salesPrior1YTDDuration516660000000JPY
Cost of salesCurrentYTDDuration563277000000JPY
Gross profitPrior1YTDDuration253298000000JPY
Gross profitCurrentYTDDuration234806000000JPY
Selling general and administrative expensesPrior1YTDDuration174287000000JPY
Selling general and administrative expensesCurrentYTDDuration170066000000JPY
Operating incomePrior1YTDDuration79010000000JPY
Operating incomeCurrentYTDDuration64739000000JPY
Interest income noiPrior1YTDDuration180000000JPY
Interest income noiCurrentYTDDuration267000000JPY
Dividends income noiPrior1YTDDuration1317000000JPY
Dividends income noiCurrentYTDDuration1414000000JPY
Equity in earnings of affiliates noiPrior1YTDDuration2574000000JPY
Equity in earnings of affiliates noiCurrentYTDDuration763000000JPY
Foreign exchange gains noiPrior1YTDDuration290000000JPY
Foreign exchange gains noiCurrentYTDDuration447000000JPY
Other noiPrior1YTDDuration1349000000JPY
Other noiCurrentYTDDuration1284000000JPY
Non operating incomePrior1YTDDuration5712000000JPY
Non operating incomeCurrentYTDDuration4176000000JPY
Interest expenses noePrior1YTDDuration385000000JPY
Interest expenses noeCurrentYTDDuration360000000JPY
Business commencement expenses noePrior1YTDDuration208000000JPY
Business commencement expenses noeCurrentYTDDuration884000000JPY
Other noePrior1YTDDuration2043000000JPY
Other noeCurrentYTDDuration1293000000JPY
Non operating expensesPrior1YTDDuration2636000000JPY
Non operating expensesCurrentYTDDuration2538000000JPY
Ordinary incomePrior1YTDDuration82086000000JPY
Ordinary incomeCurrentYTDDuration66377000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration1903000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration5681000000JPY
Gain on sales of subsidiaries and affiliates stocks eiPrior1YTDDuration2404000000JPY
Gain on sales of subsidiaries and affiliates stocks eiCurrentYTDDuration1068000000JPY
Gain on sale of capital of subsidiaries and associates eiPrior1YTDDuration－JPY
Gain on sale of capital of subsidiaries and associates eiCurrentYTDDuration1751000000JPY
Other eiPrior1YTDDuration7670000000JPY
Other eiCurrentYTDDuration310000000JPY
Extraordinary incomePrior1YTDDuration11978000000JPY
Extraordinary incomeCurrentYTDDuration8811000000JPY
Loss on abandonment of noncurrent assets elPrior1YTDDuration1961000000JPY
Loss on abandonment of noncurrent assets elCurrentYTDDuration2486000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass